Press Releases

Medix Biochemica announces the launch of its refreshed, and expanding, brand

Medix Biochemica has announced the launch of its refreshed and expanding brand to reflect both the exciting improvements to its offering as a result of recent acquisitions and its ongoing commitment to the in vitro diagnostics (IVD) industry.

WuXi STA Passes the First EMA Drug Product Pre-Approval Inspection at its Wuxi City Site

Arctoris and Evariste Technologies form a Joint Venture to Identify Novel Small Molecule cMET Inhibitors for Non-Small Cell Lung Cancer

Arctoris and Evariste Technologies have announced they have formed a joint venture to identify novel small molecule kinase inhibitors for treatment of patients with Non-Small Cell Lung Cancer (NSCLC).

Lonza Leads Market with Large and HLA-Typed CD34+ Cell Lots for Efficient Humanized Mouse Model Development

Lonza has expanded its renowned human stem cell offerings to provide human cord blood CD34+ hematopoietic stem cells (CB-CD34+ HSCs) in large batch sizes, meeting a critical and rapidly expanding market need

New, Innovative GC and GC-MS Product Portfolio Enables Greater Uptime and Efficiency

Thermo Fisher Scientific today announced the launch of its new innovative GC and GC-MS product portfolio designed to enhance usability, productivity and profitability.

Alfa Chemistry Announces Completion of Building a Sub-website for Polymer Stabilizers

CD Formulation Announces Ability to Achieve Solubility Improvement and Bioavailability Enhancement for Drug Formulation Projects

Aragen acquires Intox Pvt. Ltd

Molecular Health and collaborators prove new analytical approach that leverages real-world data to anticipate molecular causation of adverse drug reactions

Molecular Health has collaborated to announce the publication of a triad of articles that demonstrates the concept of a novel systems approach to elucidate the molecular mechanisms of drug toxicities using real-world data (RWD).

Japan tops CPhI ‘API Quality’ ranking for second year

Emmes Acquires Casimir, Its Fourth Major Acquisition

Emmes Supports New Collaboration to Accelerate COVID-19 Research for Children

FDNA Publishes Study in Nature Genetics Describing Breakthrough in AI for Rare Disease Identification

FDNA Publishes Study in Nature Genetics Describing Breakthrough in AI for Rare Disease Identification

Male fertility startup ExSeed Health secures further seed funding led by the Ascension Life Fund

● £2.5M / $3.4M investment round led by the Ascension Life Fund, with participation from Trifork, Hambro Perks, and R42 Group to fund ExSeed’s expansion. ● Seed-stage funding completed at the £5M / $6.8M mark. ● With >95% accuracy versus certified laboratory equipment, ExSeed’s CE-certified home sperm testing kit offers accurate diagnostics equivalent to traditional fertility clinics. ● Users receive a fertility score directly on their smartphone within minutes alongside a live video of their sperm sample. ● The test eliminates the need for men to attend a doctors surgery, clinic, or hospital facility, which is particularly useful while access to some medical services is restricted during the on-going Covid-19 pandemic. ● ExSeed sells both directly to consumers and collaborates with leading clinics to help treat patients at home. ● +4x revenue growth since December 2020 ● More than 10,000 tests carried out on ExSeed’s platform as of December 2021

QUOTIENT SCIENCES COMPLETES INTEGRATION OF DRUG SUBSTANCE INTO TRANSLATIONAL PHARMACEUTICS® PLATFORM

Medix Biochemica expands its molecular diagnostics business through the acquisition of myPOLS Biotec

Medix Biochemica has announced a 100% share acquisition of myPOLS Biotec GmbH (“myPOLS Biotec”).

BioAnchor Announces One-Of-A-Kind Service for Mutation-Informed Biospecimens to Support Precision Diagnostics and Therapeutics

Transforming biorepository through the rapid delivery of mutation-informed biospecimens, BIOANCHOR combines clinically relevant biosamples with comprehensive biomarker analysis, allowing researchers to acquire unique sample sets of specific cancer type and mutation of interest. The company has accumulated extensive NGS data-mining knowhow coupled with a global network, enabling greater sample-to-data access to help medical and pharmaceutical society worldwide. Applying disruptive innovation for re-purposed biorepository, bridging clinical samples and informative biomarker data, BIOANCHOR can capture sample availability, quantity and associated clinical and sequencing data from a single click, enabling our clients to tailor genotypes and phenotypes of every sample we provide.

Alfa Chemistry Materials Begins to Supply Carbon fibers for Nanotech Research

Germfree Launches Novel Mobile Cleanroom Technology for Advanced Therapies

Germfree has announced a first of its kind, mobile platform for cell and gene (CGT) therapy.

UK-made software to power millions of US lateral flow tests

An award-winning software platform made in the UK will soon allow people to easily report their Covid-19 test results to public health authorities in America, helping to track the spread of the virus. Transform®, developed by Wales-based Bond Digital Health, is being used in conjunction with a lateral flow test that is being manufactured in high volume by a major US diagnostics firm.